In 2005, more than 200,000 new cases of prostate cancer will be detected in the United States, and about 30,000 men will die from the disease. African American men are particularly hard-hit, dying from this disease at more than twice the rate of European Americans. The reasons for this racial/ethnic disparity are largely unknown, but probably involve an interaction among genetic, environmental, and social factors. This Issue Brief reviews current knowledge about the genetic basis of prostate cancer and summarizes ongoing research at Penn that investigates the role of genetics in prostate cancer treatment and outcomes
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we s...
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we s...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
In 2005, more than 200,000 new cases of prostate cancer will be detected in the United States, and a...
Genetic differences in prostate cells seem to be a root cause of the prostate cancer disparities bet...
Prostate cancer is the most common non-skin cancer and the second leading cause of cancer-related de...
Prostate cancer (CaP) is the most commonly diagnosed non-cutaneous cancer and the second leading cau...
Prostate cancer (PCa) is the second most frequently diagnosed malignancy and the second leading caus...
Disparities in cancer are common among the racial and ethnical minorities in the United States and a...
BACKGROUND: It is recognised that the risk of prostate cancer is higher in black men than in white m...
Data on the epidemiology of prostate cancer from the 1930s to the present document a dramatic racial...
Family history and African-American race are important risk factors for both prostate cancer (CaP) i...
Family history and African-American race are important risk factors for both prostate cancer (CaP) i...
In most western countries prostate cancer is the most commonly diagnosed non-skin cancer in men. Des...
Prostate cancer is the most commonly diagnosed malignancy in United States males. Unfortunately, num...
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we s...
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we s...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
In 2005, more than 200,000 new cases of prostate cancer will be detected in the United States, and a...
Genetic differences in prostate cells seem to be a root cause of the prostate cancer disparities bet...
Prostate cancer is the most common non-skin cancer and the second leading cause of cancer-related de...
Prostate cancer (CaP) is the most commonly diagnosed non-cutaneous cancer and the second leading cau...
Prostate cancer (PCa) is the second most frequently diagnosed malignancy and the second leading caus...
Disparities in cancer are common among the racial and ethnical minorities in the United States and a...
BACKGROUND: It is recognised that the risk of prostate cancer is higher in black men than in white m...
Data on the epidemiology of prostate cancer from the 1930s to the present document a dramatic racial...
Family history and African-American race are important risk factors for both prostate cancer (CaP) i...
Family history and African-American race are important risk factors for both prostate cancer (CaP) i...
In most western countries prostate cancer is the most commonly diagnosed non-skin cancer in men. Des...
Prostate cancer is the most commonly diagnosed malignancy in United States males. Unfortunately, num...
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we s...
Racial disparities in prostate cancer have not been well characterized on a genomic level. Here we s...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...